Rezolute: FDA Pivotal Trial Alignment Change Further Bolsters Ersodetug (NASDAQ:RZLT)

Core Insights - The article discusses Rezolute, Inc. (NASDAQ: RZLT) and its potential as a candidate in the pharmaceutical sector, particularly focusing on the drug RZ402 [2]. Company Overview - Rezolute, Inc. is highlighted for its innovative approaches in the biotech industry, with a specific emphasis on RZ402, which may present unexpected opportunities for investors [2]. Investment Analysis - The author provides a comprehensive analysis of Rezolute, including a model portfolio of over 10 small and mid-cap stocks, aimed at assisting healthcare investors in making informed decisions [2].